These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 11808819

  • 1. Carbamazepine decreases antihypertensive effect of nilvadipine.
    Yasui-Furukori N, Tateishi T.
    J Clin Pharmacol; 2002 Jan; 42(1):100-3. PubMed ID: 11808819
    [Abstract] [Full Text] [Related]

  • 2. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J.
    J Cardiovasc Pharmacol; 1994 Jan; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [Abstract] [Full Text] [Related]

  • 3. How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
    Kopecek M, Potmesil P.
    Neuro Endocrinol Lett; 2017 Dec; 38(7):475-478. PubMed ID: 29369597
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K, Huber HJ, Kuchlbauer R, Quitzdorff G.
    J Cardiovasc Pharmacol; 1992 Dec; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [Abstract] [Full Text] [Related]

  • 7. Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.
    Brogden RN, McTavish D.
    Drugs Aging; 1995 Feb; 6(2):150-71. PubMed ID: 7711361
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.
    Weir MR, Vlachkis ND, DeQuattro V, Douglas J, Svetkey LP, Singh S, Wiedl SC, Chen CF, Woodward DL, Saunders E.
    J Clin Pharmacol; 1990 May; 30(5):425-37. PubMed ID: 2189903
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S, Li Y, Shirasawa M, Yasui N, Fukasawa H.
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
    Hirokane G, Someya T, Takahashi S, Morita S, Shimoda K.
    Ther Drug Monit; 1999 Feb; 21(1):82-6. PubMed ID: 10051058
    [Abstract] [Full Text] [Related]

  • 15. Nilvadipine in hypertension with renal dysfunction.
    Berger HH, Albert FW.
    J Cardiovasc Pharmacol; 1992 Feb; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of nilvadipine.
    von Nieciecki A, Huber HJ, Stanislaus F.
    J Cardiovasc Pharmacol; 1992 Feb; 20 Suppl 6():S22-9. PubMed ID: 1283185
    [Abstract] [Full Text] [Related]

  • 17. Carbamazepine-nefazodone interaction in healthy subjects.
    Laroudie C, Salazar DE, Cosson JP, Cheuvart B, Istin B, Girault J, Ingrand I, Decourt JP.
    J Clin Psychopharmacol; 2000 Feb; 20(1):46-53. PubMed ID: 10653208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.